Halozyme Therapeutics, Inc. (HALO)

Halozyme Therapeutics Employees

Halozyme Therapeutics had 423 employees as of December 31, 2025. The number of employees increased by 73 or 20.86% compared to the previous year.

• Employees: 423
• Change (1Y): 73
• Growth (1Y): 20.86%
• Revenue / Employee: $3,566,095
• Profits / Employee: $824,688
• Market Cap: 7.89B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	423	73	20.86%
Dec 31, 2024	350	-23	-6.17%
Dec 31, 2023	373	-20	-5.09%
Dec 31, 2022	393	248	171.03%
Dec 31, 2021	145	9	6.62%
Dec 31, 2020	136	4	3.03%
Dec 31, 2019	132	-149	-53.02%
Dec 31, 2018	281	26	10.20%
Dec 31, 2017	255	-4	-1.54%
Dec 31, 2016	259	43	19.91%
Dec 31, 2015	216	63	41.18%
Dec 31, 2014	153	-17	-10.00%
Dec 31, 2013	170	18	11.84%
Dec 31, 2012	152	17	12.59%
Dec 31, 2011	135	33	32.35%
Dec 31, 2010	102	-38	-27.14%
Dec 31, 2009	140	10	7.69%
Dec 31, 2008	130	38	41.30%
Dec 31, 2007	92	52	130.00%
Dec 31, 2006	40	-	-

Data Source: Official company filings Last updated: Dec 31, 2025

The employees data for this stock was gathered manually by the Stock Analysis team based on SEC filings and investor relations materials.

Update frequency:

Yearly

Last checked:

May 30, 2026

Data Sources Report a data error